Renaissance Technologies - TREACE MED CONCEPTS INC ownership

TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 128 filers reported holding TREACE MED CONCEPTS INC in Q4 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of TREACE MED CONCEPTS INC
ValueSharesWeighting
Q2 2024$1,373,225
+59218.6%
206,500
+16.4%
0.00%
-50.0%
Q1 2024$2,315
+374.4%
177,400
+363.2%
0.00%
+300.0%
Q4 2023$488
-84.1%
38,302
-83.6%
0.00%
-80.0%
Q3 2023$3,068
+61.1%
234,000
+209.5%
0.01%
+66.7%
Q1 2023$1,904
+119.6%
75,600
+100.5%
0.00%
+200.0%
Q4 2022$867
-99.9%
37,700
-45.0%
0.00%
-50.0%
Q3 2022$1,514,00068,6000.00%
Other shareholders
TREACE MED CONCEPTS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Kent Lake Capital LLC 750,000$4,987,5002.25%
Soleus Capital Management, L.P. 2,365,648$15,731,5591.39%
GAGNON SECURITIES LLC 483,581$3,215,8140.72%
ARMISTICE CAPITAL, LLC 5,360,000$35,644,0000.45%
Divisadero Street Capital Management, LP 114,400$760,7600.12%
GSA CAPITAL PARTNERS LLP 191,427$1,2730.09%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 212,976$1,416,2900.09%
KORNITZER CAPITAL MANAGEMENT INC /KS 526,918$3,504,0050.07%
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 3,681,718$24,483,4250.06%
Lighthouse Investment Partners, LLC 167,500$1,113,8750.04%
View complete list of TREACE MED CONCEPTS INC shareholders